Statements (47)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:chemical_compound
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Nutrilite_Men's_Multivitamin
|
| gptkbp:activities |
antioxidant
glutathione precursor |
| gptkbp:approves |
gptkb:1963
|
| gptkbp:availability |
over-the-counter
|
| gptkbp:café |
6320
|
| gptkbp:class |
amino acid derivative
|
| gptkbp:clinical_trial |
gptkb:cystic_fibrosis
chronic obstructive pulmonary disease reducing oxidative stress preventing contrast-induced nephropathy |
| gptkbp:composed_of |
acetylation of cysteine
|
| gptkbp:denomination |
CHEBI:15712
|
| gptkbp:dissolved |
soluble in water
soluble in ethanol |
| gptkbp:financial_performance |
stable under normal conditions
|
| gptkbp:form |
gptkb:beer
gptkb:tablet powder |
| https://www.w3.org/2000/01/rdf-schema#label |
N-Acetyl Cysteine
|
| gptkbp:ingredients |
C5 H9 N O3 S
|
| gptkbp:interacts_with |
activated charcoal
nitroglycerin |
| gptkbp:is_atype_of |
R05 C B01
|
| gptkbp:is_used_for |
mucolytic agent
antidote for acetaminophen overdose |
| gptkbp:level |
approximately 6-7 in solution
|
| gptkbp:manager |
oral
intravenous |
| gptkbp:mass |
163.19 g/mol
|
| gptkbp:previous_name |
2-acetamido-3-sulfanylpropanoic acid
|
| gptkbp:products |
Cysteine
Glutathione Acetylcysteine |
| gptkbp:research |
liver diseases
cardiovascular diseases neuroprotection psychiatric disorders respiratory diseases |
| gptkbp:side_effect |
nausea
abdominal pain vomiting diarrhea |
| gptkbp:storage |
room temperature
|
| gptkbp:type_of |
616-91-1
|